The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
The endocannabinoid system: Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 1×
“More than two decades had to be waited until the first THC-specific receptor, named cannabinoid receptor type-1 (CB 1 ), could be first identified [2] and then cloned after the screening of several previously characterized orphan G-protein-coupled receptors (GPCRs) for their affinity for THC [3].”
BackgroundIsolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,587
Self-citationThe orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373 · cited 1×
“…by enzymatic hydrolysis of their amide and ester bonds, and the major enzymes responsible for these reactions have been cloned from several mammalian species and are known as fatty acid amide hydrolase (FAAH) [19] and monoacylglycerol lipase (MAGL) [20] [21], for anandamide and 2-AG, respectively.”
BackgroundA Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
Blankman, J. L., Simon, G. M., & Cravatt, B. F. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.006 · Cited by 1,177
Osei-Hyiaman, D., DePetrillo, M., Pacher, P., Liu, J., Radaeva, S., Bátkai, S., Harvey-White, J., Mackie, K., Offertáler, L., Wang, L., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523057 · Cited by 1,101
The endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090
Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305129 · Cited by 1,039
Self-citationHuang, S. M., Bisogno, T., Trevisani, M., Al-Hayani, A., De Petrocellis, L., Fezza, F., Tognetto, M., Petros, T. J., Krey, J. F., Chu, C. J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122196999 · Cited by 964
Self-citationSelective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
Long, J. Z., Li, W., Booker, L., Burston, J. J., Kinsey, S. G., Schlosburg, J. E., Pavón, F. J., Serrano, A. M., Selley, D. E., Parsons, L. H., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.129 · Cited by 934
Mezey, É., Tóth, Z. E., Cortright, D. N., Arzubi, M. K., Krause, J. E., Elde, R., Guo, A., Blumberg, P. M., & Szallasi, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3655 · Cited by 850
Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813
Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners
Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306642200 · Cited by 805
Targeting the endocannabinoid system: to enhance or reduce?
Di Marzo, V. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2553 · Cited by 798
Self-citation2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB 1 receptor
Hanuš, L., Abu-Lafi, S., Fride, E., Breuer, A., Vogel, Z., Shalev, D. E., Kustanovich, I., & Mechoulam, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061029898 · Cited by 762
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Lauckner, J. E., Jensen, J. B., Chen, H.-Y., Lu, H.-C., Hille, B., & Mackie, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711278105 · Cited by 712
Porter, A. C., Sauer, J.-M., Knierman, M. D., Becker, G. W., Berna, M. J., Bao, J., Nomikos, G. G., Carter, P., Bymaster, F. P., Leese, A. B., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1020 · Cited by 615
Pharmacological Actions of Cannabinoids
Pertwee, R. G. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_1 · Cited by 597
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease
Katona, I., & Freund, T. F. (2008) · Nature Medicine · doi:10.1038/nm.f.1869 · Cited by 579
Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons
Twitchell, W., Brown, S., & Mackie, K. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.78.1.43 · Cited by 544
Cristino, L., de Petrocellis, L., Pryce, G., Baker, D., Guglielmotti, V., & Di Marzo, V. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.074 · Cited by 491
Self-citationStructural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling
Bracey, M. H., Hanson, M. A., Masuda, K. R., Stevens, R. C., & Cravatt, B. F. (2002) · Science · doi:10.1126/science.1076535 · Cited by 490
A biosynthetic pathway for anandamide
Liu, J., Wang, L., Harvey-White, J., Osei-Hyiaman, D., Razdan, R., Gong, Q., Chan, A. C., Zhou, Z., Huang, B. X., Kim, H.-Y., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601832103 · Cited by 470
Identification of GPR55 as a lysophosphatidylinositol receptor
Oka, S., Nakajima, K., Yamashita, A., Kishimoto, S., & Sugiura, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.078 · Cited by 459
Cannabinoid Receptor Signaling
Howlett, A. C. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_2 · Cited by 446
cDNA Cloning, Tissue Distribution, and Identification of the Catalytic Triad of Monoglyceride Lipase
Karlsson, M., Contreras, J. A., Hellman, U., Tornqvist, H., & Holm, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.27218 · Cited by 422
Cadas, H., di Tomaso, E., & Piomelli, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-04-01226.1997 · Cited by 396
Kozak, K. R., Rowlinson, S. W., & Marnett, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007088200 · Cited by 390
Biochemistry and pharmacology of endovanilloids
Starowicz, K., Nigam, S., & Di Marzo, V. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.01.005 · Cited by 383
Self-citationBISOGNO, T., MELCK, D., BOBROV, M. Y., GRETSKAYA, N. M., BEZUGLOV, V. V., De PETROCELLIS, L., & Di MARZO, V. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510817 · Cited by 381
Self-citationKozak, K. R., Crews, B. C., Morrow, J. D., Wang, L.-H., Ma, Y. H., Weinander, R., Jakobsson, P.-J., & Marnett, L. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206788200 · Cited by 368
Simon, G. M., & Cravatt, B. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604660200 · Cited by 356
Leung, D., Saghatelian, A., Simon, G. M., & Cravatt, B. F. (2006) · Biochemistry · doi:10.1021/bi060163l · Cited by 350
De Petrocellis, L., Vellani, V., Schiano-Moriello, A., Marini, P., Magherini, P. C., Orlando, P., & Di Marzo, V. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134809 · Cited by 336
Self-citationEgertová, M., Giang, D. K., Cravatt, B. F., & Elphick, M. R. (1998) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.1998.0543 · Cited by 334
The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration
Ashton, J., & Glass, M. (2007) · Current Neuropharmacology · doi:10.2174/157015907780866884 · Cited by 331
Lauckner, J. E., Hille, B., & Mackie, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509588102 · Cited by 331
Jeong, W.-I., Osei-Hyiaman, D., Park, O., Liu, J., Bátkai, S., Mukhopadhyay, P., Horiguchi, N., Harvey-White, J., Marsicano, G., Lutz, B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.007 · Cited by 310
Gebremedhin, D., Lange, A. R., Campbell, W. B., Hillard, C. J., & Harder, D. R. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.6.h2085 · Cited by 308
Multiple pathways involved in the biosynthesis of anandamide
Liu, J., Wang, L., Harvey-White, J., Huang, B. X., Kim, H.-Y., Luquet, S., Palmiter, R. D., Krystal, G., Rai, R., Mahadevan, A., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.020 · Cited by 304
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum
Maccarrone, M., Rossi, S., Bari, M., De Chiara, V., Fezza, F., Musella, A., Gasperi, V., Prosperetti, C., Bernardi, G., Finazzi-Agrò, A., et al. (2008) · Nature Neuroscience · doi:10.1038/nn2042 · Cited by 295
Endocannabinoids and the regulation of their levels in health and disease
Di Marzo, V., & Petrosino, S. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32803dbdec · Cited by 289
Self-citationHenstridge, C. M., Balenga, N. A. B., Ford, L. A., Ross, R. A., Waldhoer, M., & Irving, A. J. (2009) · The FASEB Journal · doi:10.1096/fj.08-108670 · Cited by 285
Evidence against the presence of an anandamide transporter
Glaser, S. T., Abumrad, N. A., Fatade, F., Kaczocha, M., Studholme, K. M., & Deutsch, D. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730816100 · Cited by 279
BISOGNO, T., SEPE, N., MELCK, D., MAURELLI, S., PETROCELLIS, L. D., & MARZO, V. D. (1997) · Biochemical Journal · doi:10.1042/bj3220671 · Cited by 275
The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt
del Pulgar, T. G., Velasco, G., & Guzmán, M. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470369 · Cited by 259
Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects
Onaivi, E. S., Ishiguro, H., Gong, J.-P., Patel, S., Meozzi, P. A., Myers, L., Perchuk, A., Mora, Z., Tagliaferro, P. A., Gardner, E., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001640 · Cited by 257
Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels
van der Stelt, M., Trevisani, M., Vellani, V., De Petrocellis, L., Schiano Moriello, A., Campi, B., McNaughton, P., Geppetti, P., & Di Marzo, V. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600784 · Cited by 245
Self-citationHemopressin is an inverse agonist of CB 1 cannabinoid receptors
Heimann, A. S., Gomes, I., Dale, C. S., Pagano, R. L., Gupta, A., de Souza, L. L., Luchessi, A. D., Castro, L. M., Giorgi, R., Rioli, V., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706980105 · Cited by 242
SUN, Y.-X., TSUBOI, K., OKAMOTO, Y., TONAI, T., MURAKAMI, M., KUDO, I., & UEDA, N. (2004) · Biochemical Journal · doi:10.1042/bj20040031 · Cited by 235
Jekyll and Hyde: Two Faces of Cannabinoid Signaling in Male and Female Fertility
Wang, H., Dey, S. K., & Maccarrone, M. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0006 · Cited by 232
Beltramo, M., & Piomelli, D. (2000) · NeuroReport · doi:10.1097/00001756-200004270-00018 · Cited by 230
The endocannabinoid system: emotion, learning and addiction
Moreira, F. A., & Lutz, B. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00104.x · Cited by 222
Regulation of PI3K/Akt/GSK‐3 pathway by cannabinoids in the brain
Ozaita, A., Puighermanal, E., & Maldonado, R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04642.x · Cited by 216
Pertwee, R. G. (2005) · The AAPS Journal · doi:10.1208/aapsj070364 · Cited by 203
Discovery and Development of Fatty Acid Amide Hydrolase (FAAH) Inhibitors
Seierstad, M., & Breitenbucher, J. G. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800311k · Cited by 179
Waldeck-Weiermair, M., Zoratti, C., Osibow, K., Balenga, N., Goessnitzer, E., Waldhoer, M., Malli, R., & Graier, W. F. (2008) · Journal of Cell Science · doi:10.1242/jcs.020958 · Cited by 177
Oxidative metabolism of endocannabinoids
Kozak, K. R., & Marnett, L. J. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0359 · Cited by 170
van der Stelt, M., van Kuik, J. A., Bari, M., van Zadelhoff, G., Leeflang, B. R., Veldink, G. A., Finazzi‐Agrò, A., Vliegenthart, J. F. G., & Maccarrone, M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020818q · Cited by 168
Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist
Ueda, N., Yamamoto, K., Yamamoto, S., Tokunaga, T., Shirakawa, E., Shinkai, H., Ogawa, M., Sato, T., Kudo, I., Inoue, K., et al. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)00170-4 · Cited by 167
Ellert-Miklaszewska, A., Kaminska, B., & Konarska, L. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2004.05.011 · Cited by 165
Sugiura, T., Kodaka, T., Kondo, S., Tonegawa, T., Nakane, S., Kishimoto, S., Yamashita, A., & Waku, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1757 · Cited by 164
Bisogno, T., Melck, D., De Petrocellis, L., & Di Marzo, V. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722113.x · Cited by 162
Self-citationPETROCELLIS, L. D., Starowicz, K., Moriello, A. S., Vivese, M., Orlando, P., & Marzo, V. D. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.01.008 · Cited by 161
Guzmán, M., Sánchez, C., & Galve-Roperh, I. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00256-5 · Cited by 161
Marinelli, S., Marzo, V. D., Florenzano, F., Fezza, F., Viscomi, M. T., van der Stelt, M., Bernardi, G., Molinari, M., Maccarrone, M., & Mercuri, N. B. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301118 · Cited by 161
The uptake by cells of 2‐arachidonoylglycerol, an endogenous agonist of cannabinoid receptors
Bisogno, T., Maccarrone, M., De Petrocellis, L., Jarrahian, A., Finazzi‐Agrò, A., Hillard, C., & Di Marzo, V. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02072.x · Cited by 160
Self-citationProstamides (prostaglandin‐ethanolamides) and their pharmacology
Woodward, D. F., Liang, Y., & Krauss, A. H. ‐. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707434 · Cited by 158
SANCHEZ, M. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(03)00036-6 · Cited by 158
Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?
Kunos, G., Osei‐Hyiaman, D., Bátkai, S., Sharkey, K. A., & Makriyannis, A. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.10.001 · Cited by 141
Prostaglandin Ethanolamides (Prostamides): In Vitro Pharmacology and Metabolism
Matias, I., Chen, J., PETROCELLIS, L. D., Bisogno, T., Ligresti, A., Fezza, F., Krauss, A. H. ‐., Shi, L., Protzman, C. E., Li, C., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061705 · Cited by 128
Development of the first potent and specific inhibitors of endocannabinoid biosynthesis
Bisogno, T., Cascio, M. G., Saha, B., Mahadevan, A., Urbani, P., Minassi, A., Appendino, G., Saturnino, C., Martin, B. R., Razdan, R. K., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.12.009 · Cited by 123
Nyilas, R., Dudok, B., Urbán, G. M., Mackie, K., Watanabe, M., Cravatt, B. F., Freund, T. F., & Katona, I. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5102-07.2008 · Cited by 119
Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock‐out mice
Pacher, P., Bátkai, S., & Kunos, G. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.064824 · Cited by 119
Signaling via CNS cannabinoid receptors
Mackie, K. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.01.022 · Cited by 118
Edgemond, W. S., Hillard, C. J., Falck, J. R., Kearn, C. S., & Campbell, W. B. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.180 · Cited by 116
Cristino, L., Starowicz, K., De Petrocellis, L., Morishita, J., Ueda, N., Guglielmotti, V., & Di Marzo, V. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.11.047 · Cited by 115
Nirodi, C. S., Crews, B. C., Kozak, K. R., Morrow, J. D., & Marnett, L. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0303950101 · Cited by 113
Egertová, M., Simon, G. M., Cravatt, B. F., & Elphick, M. R. (2008) · Journal of Comparative Neurology · doi:10.1002/cne.21568 · Cited by 111
FAAH and anandamide: is 2-AG really the odd one out?
Marzo, V. D., & Maccarrone, M. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.03.001 · Cited by 111
Marzo, V. D., PETROCELLIS, L. D., Sugiura, T., & Waku, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1501 · Cited by 110
Marinelli, S., Pacioni, S., Bisogno, T., Marzo, V. D., Prince, D. A., Huguenard, J. R., & Bacci, A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0847-08.2008 · Cited by 109
Esposito, I., Proto, M., Gazzerro, P., Laezza, C., Miele, C., Alberobello, A. T., D’Esposito, V., Bèguinot, F., Formisano, P., & Bifulco, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.049205 · Cited by 108
Protective activation of the endocannabinoid system during ischemia in dopamine neurons
Melis, M., Pillolla, G., Bisogno, T., Minassi, A., Petrosino, S., Perra, S., Muntoni, A. L., Lutz, B., Gessa, G. L., Marsicano, G., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.010 · Cited by 107
The Endocannabinoid Anandamide Is a Substrate for the Human Polymorphic Cytochrome P450 2D6
Snider, N. T., Sikora, M. J., Sridar, C., Feuerstein, T. J., Rae, J. M., & Hollenberg, P. F. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141796 · Cited by 104
Fatty Acid Amide Hydrolase: A Gate-Keeper of the Endocannabinoid System
Fezza, F., De Simone, C., Amadio, D., & Maccarrone, M. (2008) · Subcellular Biochemistry · doi:10.1007/978-1-4020-8831-5_4 · Cited by 99 · cited 1×
“More and more such inhibitors are being developed, and they include both reversible and irreversible inhibitors (see [111] [112] for reviews).”
BackgroundAllosterism and cannabinoid CB1 receptors: the shape of things to come
ROSS, R. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.006 · Cited by 93
Ortega‐Gutiérrez, S., Hawkins, E. G., Viso, A., López-Rodríguez, M. L., & Cravatt, B. F. (2004) · Biochemistry · doi:10.1021/bi049395f · Cited by 93
Liang, Y., Woodward, D. F., Guzman, V. M., Li, C., Scott, D. F., Wang, J. W., Wheeler, L. A., Garst, M. E., Landsverk, K., Sachs, G. M., et al. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.142 · Cited by 93
Ho, B. Y., Uezono, Y., Takada, S., Takase, I., & Izumi, F. (1999) · PubMed · Cited by 88
Tetrahydrolipstatin Analogues as Modulators of Endocannabinoid 2-Arachidonoylglycerol Metabolism
Ortar, G., Bisogno, T., Ligresti, A., Morera, E., Nalli, M., & Marzo, V. D. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800978m · Cited by 86
Bisogno, T., Ortar, G., Petrosino, S., Morera, E., Palazzo, E., Nalli, M., Maione, S., & Marzo, V. D. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.10.007 · Cited by 77
DEPETROCELLIS, L., Marini, P., Matias, I., Moriello, A. S., Starowicz, K., Cristino, L., Nigam, S., & Marzo, V. D. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.05.012 · Cited by 70
Ligresti, A., Cascio, M. G., Pryce, G., Kulasegram, S., Beletskaya, I., PETROCELLIS, L. D., Saha, B., Mahadevan, A., Visintin, C., Wiley, J. L., et al. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706418 · Cited by 69
Microsomal cytochrome P450-mediated liver and brain anandamide metabolism
Bornheim, L. M., Kim, K. Y., Chen, B., & Correia, M. A. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00177-2 · Cited by 68
Bisogno, T., & Marzo, V. D. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.002 · Cited by 68
Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: A critical revisitation
Ortar, G., Cascio, M. G., Moriello, A. S., Camalli, M., Morera, E., Nalli, M., & Marzo, V. D. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.02.023 · Cited by 63
Newman, Z., Malik, P., Wu, T., Ochoa, C. J., Watsa, N., & Lindgren, C. A. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05422.x · Cited by 57
Sergeeva, O. A., Doreulee, N., Chepkova, A. N., Kazmierczak, T., & Haas, H. L. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05815.x · Cited by 55
Bisogno, T., Burston, J. J., Rai, R., Allarà, M., Saha, B., Mahadevan, A., Razdan, R. K., Wiley, J. L., & Marzo, V. D. (2009) · ChemMedChem · doi:10.1002/cmdc.200800442 · Cited by 51
Jones, J. D., Carney, S. T., Vrana, K. E., Norford, D. C., & Howlett, A. C. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.027 · Cited by 50
Mulder, A. M., & Cravatt, B. F. (2006) · Biochemistry · doi:10.1021/bi061122s · Cited by 45
Endothelial CB1-receptors limit infarct size through NO formation in rat isolated hearts
Lépicier, P., Lagneux, C., Sirois, M. G., & Lamontagne, D. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.08.042 · Cited by 43
Vila, A., Rosengarth, A., Piomelli, D., Cravatt, B. F., & Marnett, L. J. (2007) · Biochemistry · doi:10.1021/bi7005898 · Cited by 37
Stefano, G. B., Esch, T., Cadet, P., Zhu, W. M., Mantione, K. J., & Benson, H. (2003) · PubMed · Cited by 36
Why endocannabinoids are not all alike
Marzo, V. D., & Cristino, L. (2008) · Nature Neuroscience · doi:10.1038/nn0208-124 · Cited by 35
Maione, S., Morera, E., Marabese, I., Ligresti, A., Luongo, L., Ortar, G., & Marzo, V. D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.308 · Cited by 33
Development of the First Potential Covalent Inhibitors of Anandamide Cellular Uptake
Moriello, A. S., Balas, L., Ligresti, A., Cascio, M. G., Durand, T., Morera, E., Ortar, G., & Marzo, V. D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051226l · Cited by 24
Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake?
Fowler, C. J., & Ghafouri, N. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.07.002 · Cited by 23
“The Tools of the Trade” – An Overview of the Pharmacology of the Endocannabinoid System
Fowler, C. J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740126 · Cited by 22
Thomas, M. (2009) · SecEd · doi:10.12968/sece.2009.1.1395 · Cited by 17
Cited by
FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and Signaling
Zechner, R., Zimmermann, R., Eichmann, T. O., Kohlwein, S. D., Haemmerle, G., Lass, A., & Madeo, F. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.018 · Cited by 1,132
Endocannabinoid Signaling and Synaptic Function
Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.020 · Cited by 1,120
Cannabinoids and the gut: New developments and emerging concepts
Izzo, A. A., & Sharkey, K. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.12.005 · Cited by 419
Iannotti, F. A., Di Marzo, V., & Petrosino, S. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.02.002 · Cited by 357
Self-citationBiochemistry and pathophysiology of intravascular and intracellular lipolysis
Young, S. G., & Zechner, R. (2013) · Genes & Development · doi:10.1101/gad.209296.112 · Cited by 348
Metadata
- Authors
- Di Marzo, V.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 60
- Issue
- 2
- Pages
- 77-84
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2115351521
- Cited by
- 368
- References
- 122
- FWCI
- 26.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.